
    
      OBJECTIVES:

        -  Determine the objective response and clinical outcome in patients with duodenal
           obstruction secondary to malignancy treated with enteral Wallstents.

        -  Evaluate the efficacy and safety of this treatment in these patients.

        -  Evaluate the quality of life of these patients after enteral Wallstent placement.

      OUTLINE: Patients undergo enteral Wallstent placement through an endoscope under fluoroscopic
      guidance into the duodenum.

      Quality of life is assessed at 48 hours and 6 months after procedure.

      Patients are followed at 48 hours, 30 days, 6 months, and then yearly thereafter until death.

      PROJECTED ACCRUAL: A total of 20 patients will be accrued for this study.
    
  